COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline Market Report Overview

Nucleic Acid Amplification Tests (NAAT) involve the amplification of specific nucleic acid sequences of the SARS-CoV-2 virus by targeting specific nucleic acid sequences. NAAT exhibits better sensitivity in comparison to other antigen identification methods.

The COVID-19 NAATs pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·        China

·        Europe

Key Regulatory Paths ·        NMPA
Leading Companies ·        Age Labs AS

·        Chengdu One-Chip Biotechnology Co Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

COVID-19 NAATs Pipeline Market Segmentation by Territories

The key territories for the COVID-19 NAATs pipeline products are China and Europe. As of December 2023, both China and Europe had an equal number of pipeline products.

COVID-19 NAATs Pipeline Market Analysis by Territories, 2023 (%)

COVID-19 NAATs Pipeline Market Analysis by Territories, 2023 (%)
Buy the Full Report for More Territory Insights into the COVID-19 NAATs Pipeline Market
Download a Free Report Sample

COVID-19 NAATs Pipeline Market Segmentation by Regulatory Paths

As of December 2023, NMPA is the most followed pathway for pipeline products in the market.

Buy the Full Report for More Regulatory Path Insights into the COVID-19 NAATs Pipeline Market
Download a Free Report Sample

COVID-19 NAATs Pipeline Market – Competitive Landscape

The key companies in the COVID-19 NAATs pipeline market are:

  • Age Labs AS
  • Chengdu One-Chip Biotechnology Co Ltd

Age Labs AS: Headquartered in Norway, Age Labs AS, is a biotechnology company that develops diagnostics for the early detection of age-related diseases.

COVID-19 NAATs Pipeline Market Analysis by Companies, 2023

COVID-19 NAATs Pipeline Market Analysis by Companies, 2023
Buy the Full Report for More Company Insights into the COVID-19 NAATs Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

COVID-19 NAATs Pipeline Market Territories Outlook

  • China
  • Europe

COVID-19 NAATs Pipeline Market Regulatory Paths Outlook

  • NMPA

Scope

This report provides:

  • Extensive coverage of the COVID-19 NAATs under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in pipeline product development and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report will enable you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of COVID-19 NAATs under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Age Labs AS
Chengdu One-Chip Biotechnology Co Ltd

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 4

|1.2 List of Figures 5

2 Introduction 6

2.1 COVID 19 Nucleic Acid Amplification Tests (NAATs) Overview 6

3 Products under Development 7

3.1 COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Stage of Development 7

3.2 COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Territory 8

3.3 COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Regulatory Path 9

3.4 COVID 19 Nucleic Acid Amplification Tests (NAATs) – Ongoing Clinical Trials 10

4 COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products under Development by Companies 11

4.1 COVID 19 Nucleic Acid Amplification Tests (NAATs) Companies – Pipeline Products by Stage of Development 11

4.2 COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Stage of Development 12

5 COVID 19 Nucleic Acid Amplification Tests (NAATs) Companies and Product Overview 13

5.1 Age Labs AS Company Overview 13

5.1.1 Age Labs AS Pipeline Products & Ongoing Clinical Trials Overview 13

5.2 Chengdu One-Chip Biotechnology Co Ltd Company Overview 14

5.2.1 Chengdu One-Chip Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 14

6 COVID 19 Nucleic Acid Amplification Tests (NAATs)- Recent Developments 17

6.1 Nov 29, 2023: BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief Commercial Officer 17

6.2 Oct 30, 2023: Cepheid Receives 510(K) Clearance For Xpert Xpress CoV-2 Plus Test 17

6.3 Mar 17, 2023: When time matters, rapid point of care testing can support treatment decisions 18

6.4 Mar 15, 2023: Cepheid receives Health Canada Licence for Xpert Xpress CoV-2 plus 18

7 Appendix 19

7.1 Methodology 19

7.2 About GlobalData 22

7.3 Contact Us 22

7.4 Disclaimer 22

Table

COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Stage of Development 6

COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Territory 7

COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Regulatory Path 8

COVID 19 Nucleic Acid Amplification Tests (NAATs) – Ongoing Clinical Trials 9

COVID 19 Nucleic Acid Amplification Tests (NAATs) Companies – Pipeline Products by Stage of Development 10

COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Stage of Development 11

Age Labs AS Pipeline Products & Ongoing Clinical Trials Overview 12

Blood Test – Covid 19 – Product Status 12

Blood Test – Covid 19 – Product Description 12

Chengdu One-Chip Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 13

Coronavirus (2019-nCoV) Nucleic Acid Detection Kit – Product Status 13

Coronavirus (2019-nCoV) Nucleic Acid Detection Kit – Product Description 13

Chengdu One-Chip Biotechnology Co Ltd – Ongoing Clinical Trials Overview 14

Coronavirus (2019-nCoV) Nucleic Acid Detection Kit – Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit (Isothermal Amplification Method) Clinical Trial 15

Glossary 20

Figures

COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Stage of Development 7_x000D_

COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Territory 8_x000D_

COVID 19 Nucleic Acid Amplification Tests (NAATs) – Pipeline Products by Regulatory Path 9_x000D_

COVID 19 Nucleic Acid Amplification Tests (NAATs) – Ongoing Clinical Trials 10_x000D_

Frequently asked questions

COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies in real time.

  • Access a live COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.